跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 31 条关于
“SKB378/HBM9378”
全部
31
临床试验
19
药物
2
机构
0
资讯
10
去年
Windward Bio Secures Global License for Anti-TSLP Antibody SKB378/HBM9378 in $970M Deal
去年
HBM Holdings Secures NMPA Approval to Begin COPD Drug Trials in China
9天前
Kelun-Biotech and Windward Bio Report Positive Phase 2 Interim Data for Twice-Yearly Asthma Antibody SKB378/WIN378
6个月前
Harbour BioMed's TSLP-Targeting Antibody HBM9378 Shows Favorable Safety Profile in Phase I Trial
去年
Long-Acting Anti-TSLP Antibody HBM9378/WIN378 Enters Global Phase 2 Trial for Asthma Treatment
9天前
Harbour BioMed's TSLP Antibody HBM9378 Delivers 24-Week Asthma Control After Single Dose, Supporting Twice-Yearly Regimen
上个月
Harbour BioMed Reports Seventh Consecutive Profitable Half-Year, Driven by Strategic Collaborations and AI-Enabled Pipeline Advances
去年
Kelun-Biotech's SKB571 Receives Green Light for Clinical Trials
去年
Kelun-Biotech's SKB571 Receives Green Light for Clinical Trials in Solid Tumors
2个月前
NMPA Clears IND for HBM7575/SKB575, a Long-Acting TSLP Bispecific Antibody for Asthma